677 related articles for article (PubMed ID: 24966953)
21. The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: incidence of disease entities by age groups.
Cho EY; Kim KH; Kim WS; Yoo KH; Koo HH; Ko YH
J Korean Med Sci; 2008 Apr; 23(2):185-92. PubMed ID: 18436998
[TBL] [Abstract][Full Text] [Related]
22. Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders.
Iwatsuki K; Miyake T; Hirai Y; Yamamoto T
Eur J Dermatol; 2019 Feb; 29(1):21-28. PubMed ID: 30998212
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological findings of systemic Epstein-Barr virus-positive T-lymphoproliferative diseases in younger and older adults.
Wang Z; Kimura S; Iwasaki H; Takase K; Oshiro Y; Gamachi A; Makihara K; Ogata M; Daa T; Momosaki S; Takamatsu Y; Takeshita M
Diagn Pathol; 2021 Jun; 16(1):48. PubMed ID: 34088321
[TBL] [Abstract][Full Text] [Related]
24. Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome.
Quintanilla-Martinez L; Kumar S; Fend F; Reyes E; Teruya-Feldstein J; Kingma DW; Sorbara L; Raffeld M; Straus SE; Jaffe ES
Blood; 2000 Jul; 96(2):443-51. PubMed ID: 10887104
[TBL] [Abstract][Full Text] [Related]
25. A clinicopathologic study of the spectrum of systemic forms of EBV-associated T-cell lymphoproliferative disorders of childhood: A single tertiary care pediatric institution experience in North America.
Coffey AM; Lewis A; Marcogliese AN; Elghetany MT; Punia JN; Chang CC; Allen CE; McClain KL; Gaikwad AS; El-Mallawany NK; Curry CV
Pediatr Blood Cancer; 2019 Aug; 66(8):e27798. PubMed ID: 31099136
[TBL] [Abstract][Full Text] [Related]
26. NK-cell post-transplant lymphoproliferative disease with chronic active Epstein-Barr virus infection-like clinical findings.
Iemura T; Kondo T; Hishizawa M; Yamashita K; Kimura H; Takaori-Kondo A
Int J Infect Dis; 2019 Nov; 88():31-33. PubMed ID: 31398454
[TBL] [Abstract][Full Text] [Related]
27. Quantification of Epstein-Barr virus DNA is helpful for evaluation of chronic active Epstein-Barr virus infection.
Sakamoto Y; Mariya Y; Kubo K
Tohoku J Exp Med; 2012 Aug; 227(4):307-11. PubMed ID: 22850617
[TBL] [Abstract][Full Text] [Related]
28. The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.
Smith MC; Cohen DN; Greig B; Yenamandra A; Vnencak-Jones C; Thompson MA; Kim AS
Int J Clin Exp Pathol; 2014; 7(9):5738-49. PubMed ID: 25337215
[TBL] [Abstract][Full Text] [Related]
29. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
Kimura H
Rev Med Virol; 2006; 16(4):251-61. PubMed ID: 16791843
[TBL] [Abstract][Full Text] [Related]
30. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes.
El-Mallawany NK; Curry CV; Allen CE
Br J Haematol; 2022 Jan; 196(1):31-44. PubMed ID: 34169507
[TBL] [Abstract][Full Text] [Related]
31. Application of flow cytometric in situ hybridization assay to Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases.
Kawabe S; Ito Y; Gotoh K; Kojima S; Matsumoto K; Kinoshita T; Iwata S; Nishiyama Y; Kimura H
Cancer Sci; 2012 Aug; 103(8):1481-8. PubMed ID: 22497716
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Disorders Manifested as Gastrointestinal Perforations and Skin Lesions: A Case Report.
Xiao HJ; Li J; Song HM; Li ZH; Dong M; Zhou XG
Medicine (Baltimore); 2016 Feb; 95(5):e2676. PubMed ID: 26844502
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy.
Hirai Y; Asada H; Hamada T; Kawada JI; Kimura H; Arai A; Ohshima K; Ohga S; Iwatsuki K;
J Dermatol; 2023 Jul; 50(7):e198-e205. PubMed ID: 37249004
[TBL] [Abstract][Full Text] [Related]
34. Inherited Genetic Susceptibility to Nonimmunosuppressed Epstein-Barr Virus-associated T/NK-cell Lymphoproliferative Diseases in Chinese Patients.
Guan YQ; Shen KF; Yang L; Cai HD; Zhang ML; Wang JC; Long XL; Xiong J; Gu J; Zhang PL; Xiao M; Zhang W; Zhou JF
Curr Med Sci; 2021 Jun; 41(3):482-490. PubMed ID: 34170459
[TBL] [Abstract][Full Text] [Related]
35. Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients.
Cao P; Zhang M; Wang W; Dai Y; Sai B; Sun J; Wang L; Wang F; Li G; Xiang J
BMC Infect Dis; 2017 May; 17(1):323. PubMed ID: 28468603
[TBL] [Abstract][Full Text] [Related]
36. [Systemic EBV+ T-cell lymphoproliferative disease of childhood].
Lemaire AS; Daussay D; Bouchindhomme B; Grardel N; Botte A; Copin MC
Ann Pathol; 2014 Aug; 34(4):339-43. PubMed ID: 25132446
[TBL] [Abstract][Full Text] [Related]
37. Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells.
Collins PJ; Fox CP; George L; Pearce H; Ryan G; De Santo C; Mussai F; Lewis D; Long H; Shannon-Lowe C
Blood; 2021 Jan; 137(2):203-215. PubMed ID: 33443553
[TBL] [Abstract][Full Text] [Related]
38. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.
Kimura H; Ito Y; Kawabe S; Gotoh K; Takahashi Y; Kojima S; Naoe T; Esaki S; Kikuta A; Sawada A; Kawa K; Ohshima K; Nakamura S
Blood; 2012 Jan; 119(3):673-86. PubMed ID: 22096243
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
[TBL] [Abstract][Full Text] [Related]
40. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
Hart M; Thakral B; Yohe S; Balfour HH; Singh C; Spears M; McKenna RW
Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]